PureTech publishes Phase 2b trial results for IPF drug candidate.
Share this article
Earnings
Score 25
Neutral
PureTech publishes Phase 2b trial results for IPF drug candidate
Apr 02, 2026 12:25 UTC
PTI
Short term
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.